Phase 3 THOR study: Results of erdafitinib (erda) versus chemotherapy (chemo) in patients (pts) with advanced or metastatic urothelial cancer (mUC) with select fibroblast growth factor receptor alterations (FGFRalt)
Loading...
Embargo End Date
ICR Authors
Authors
Loriot, Y
Matsubara, N
Park, SH
Huddart, RA
Burgess, EF
Houede, N
Banek, S
Laguerre, B
Guadalupi, V
Ku, JH
Triantos, S
Akapame, S
Deprince, K
Mukhopadhyay, S
Siefker-Radtke, AO
Matsubara, N
Park, SH
Huddart, RA
Burgess, EF
Houede, N
Banek, S
Laguerre, B
Guadalupi, V
Ku, JH
Triantos, S
Akapame, S
Deprince, K
Mukhopadhyay, S
Siefker-Radtke, AO
Document Type
Conference Proceeding
Date
2023-06-10
Date Accepted
2023-09-11
Abstract
Citation
Journal of Clinical Oncology, 2023, 41 (17),
DOI
Source Title
Journal of Clinical Oncology
Publisher
LIPPINCOTT WILLIAMS & WILKINS
ISSN
0732-183X
eISSN
1527-7755
1527-7755
1527-7755
Collections
Research Team
Clinic Acad RT Huddart